ODS
Develops and sells proprietary 3D printing resins and printers for direct manufacturing of dental clear aligners, enabling a streamlined digital workflow from scan to finished appliance.
- CEO / Founder
- Park Sung-won
- Team Size
- 11-50
- Stage
- Active
- Total Funding
- Undisclosed
- Latest Round
- Series A
- Key Investors
- 다산에스비에이재기투자조합 (Dasan SB Aegis Investment Union)
Technology & Products
Key Products
AlignMiracle (direct 3D printed clear aligner system); Dental 3D printing resins (MODEL, etc.); 3D printers for dental applications
Technological Advantage
Proprietary photocurable resin formulations and printing process for direct manufacturing of clear orthodontic aligners, protected by multiple patents (e.g., US11660814B2, EP4219570A1). The technology bypasses traditional thermoforming, aiming for improved accuracy and faster turnaround. Clinical validation through the ADA Forsyth Institute partnership is a critical step towards regulatory clearance and building a qualification-based moat.
Differentiation
Value Proposition
Reduces clear aligner production time and cost by eliminating the multi-step thermoforming process, while improving fit precision through direct 3D printing of biocompatible, transparent appliances.
How They Differentiate
Focuses on a fully integrated direct-print workflow for clear aligners, as opposed to the dominant indirect thermoforming model. Competes on speed and potential precision, but lacks the scale and regulatory clearance of market leaders like Align Technology.
Market & Competition
Target Customers
Dental labs, orthodontic clinics, and clear aligner manufacturers seeking to transition from indirect thermoforming to direct 3D printing.
Industry Verticals
Dental; Orthodontics
Competitors
Align Technology (iTero/Invisalign system); Dentsply Sirona; Straumann Group (including ClearCorrect); Formlabs (dental segment); Carbon (dental segment)
Growth & Milestones
Growth Metrics
2024 revenue: 14.9 billion KRW; 2024 operating profit: -14.3 billion KRW; FDA 510(k) clearance for Clear Miracle resin obtained in September 2025; Material is used in actual patient treatment at Chung-Ang University Gwangmyeong Hospital's orthodontics department; Business focuses on two areas: dental 3D printing resin development and application development.
Major Milestones
2017: Company renamed to '주식회사 ODS' and received Excellent Technology Enterprise certification.; 2026: Gold Sponsor and keynote presenter at inaugural ADA Forsyth Dentech-Asia conference.; Ongoing US clinical trials for AlignMiracle in partnership with ADA Forsyth Institute.
Notable Customers
Chung-Ang University Gwangmyeong Hospital (중앙대학교 광명병원); ADA Forsyth Institute (clinical partner); Straumann (collaboration experience mentioned)